Biotech & Healthtech
CRISPR Diagnostics vs. RT-PCR: A New Era for Rapid Testing
CRISPR-based diagnostic platforms are emerging as faster, more accessible alternatives to RT-PCR, offering significant advantages in speed and portability for point-of-care and decentralized testing. This shift promises to revolutionize infectious disease response by enabling rapid nucleic acid detection outside traditional laboratories.
Mateo Rossi·October 7, 2026